Aims To examine the survival of patients admitted with a suspected acute myocardial infarction in whom the diagnosis was not confirmed ('possible myocardial infarction').
Introduction
Patients admitted to hospital with chest pain suggestive of acute myocardial infarction account for up to 35% of all acute emergencies and make up the largest single group of patients admitted in this way [1] . Using established WHO criteria based on the clinical history, serial cardiac enzyme and ECG changes [2, 3] , some patients will develop major changes sufficient to diagnose an acute myocardial infarction or minor changes suggestive of another acute coronary syndrome such as a non-Q wave myocardial infarction or unstable angina. In others, the lack of ECG or enzyme changes may suggest a diagnosis of non-cardiac chest pain.
Describing these varied clinical presentations is complicated by a challenging array of international definitions [3] . In the U.K. one definition within which many of these patients with an unconfirmed myocardial infarction have been grouped is 'possible myocardial infarction' [5] [6] . These patients have some non-diagnostic change in their ECG or a slight rise in cardiac enzymes. Unlike myocardial infarction, these patients are less well investigated and available data is restricted to the late 1970s [5] or to patients from other countries [7] where differing case definitions make direct comparisons difficult. However, increasing numbers of admissions, increasing age at presentation [2] and substantial resource use [8] make this group of patients a significant component of the workload of most U.K. district general hospitals. Patients in the 'possible myocardial infarction' category comprise a heterogeneous group with acute coronary syndromes as well as non-cardiac chest pain. Since 'possible myocardial infarction' patients may comprise over 50% of all chest pain admission [6, 9] , this single group of patients may be responsible for almost one in five of all acute medical admissions to hospital.
Over 25 years ago, it was observed that the mortality of patients discharged from hospital following a suspected myocardial infarction, in whom the diagnosis was not confirmed, was higher than in those discharged alive who had suffered a myocardial infarction [10] . In the U.K., this observation has not been widely explored since.
The aims of this study were to describe the survival of a cohort of patients admitted with a suspected myocardial infarction, where the diagnosis was not confirmed (categorized as a 'possible myocardial infarction' group), compared with a normal population and with a cohort with a confirmed myocardial infarction; and to describe the cause of death.
Methods

Assembling cases for the Nottingham Heart Attack Register (NHAR)
The NHAR has collected data on patients admitted with suspected myocardial infarction since 1973. All patients admitted to Nottingham's two acute hospitals were eligible for inclusion on the register. The operation and case definitions used in the register have been reported elsewhere [6, 9] . In brief, the main definitions used in the register were: Definite myocardial infarction: good history for acute myocardial infarction and electrocardiograph (ECG) changes of myocardial infarction (development of new Q waves) and rises in two cardiac enzymes (lactate dehydrogenase and creatine phosphokinase) to above twice the upper limit of normal. Probable myocardial infarction: good history for acute myocardial infarction and new Q waves or rises in two cardiac enzymes to above twice the upper limit of normal Possible myocardial infarction: good history for acute myocardial infarction and either ECG changes other than new Q waves or a rise in cardiac enzymes but to less than twice the upper limit of normal, or both. Ischaemic heart disease: good history for acute myocardial infarction and 'old' pathological Q waves but no new changes and cardiac enzymes in the normal range. Chest pain (? cause): Good history for acute myocardial infarction but ECG and cardiac enzymes were normal on admission and subsequently.
Additional categories for other diagnoses were also available. In arriving at the case definitions, diagnostic coding was based on cardiac enzyme and ECG findings during the index admission only. The ECG changes used in the case definition refer to any transient or sustained abnormality of the ECG (except the development of Q waves) that was present at any time during the index admission, based on available ECGs. The NHAR case definitions do not set criteria linking the timing of symptoms to transient ECG changes, as with some angina studies. Definite and probable myocardial infarction are grouped as 'confirmed myocardial infarction' in this report.
Availability of clinical information
Extensive clinical information on in-hospital course and discharge medication was available on each patient on the NHAR, based on information collected from patient notes up to the time of hospital discharge from the index event. In addition, an 'initial working diagnosis' was recorded by NHAR based on information in the clinical notes of the index admission.
Tracing patients listed on the NHAR
The records of all admissions listed by the NHAR for 1992 in the 'possible myocardial infarction' category were scrutinized. For the purposes of this study, the index admission was the first admission with the diagnosis of possible myocardial infarction during the year 1992, and patients had to be resident in the Nottingham District Health Authority (DHA) area at the time of that index admission.
Patients' records were traced using the DHA computer database of patients currently registered with local general practitioners (GPs). The DHA computer contained data on all patients who had ever been registered with Nottingham GPs back to 1986 and was updated electronically from individual general practices each day. Death registration returns from the Office of National Statistics (ONS) for Nottingham residents up to and including the last day of December 1997 were also used. Patient records were matched using surname, first name, date of birth and recorded address at the time of the index admission.
Identification of cause of death
Death registration data from the Office of National Statistics containing International Classification of Disease revision 9 (ICD-9) coded information was used to determine the cause of death [11] . It was not, however, possible to define a 'main cause of death' as recorded by Office of National Statistics, on all patients. This was due to a change in the convention and coding system used to identify the main cause of death in 1993 [12] . Electronic records supplied by Office of National Statistics prior to 1994 did not come with a summary Cause of Death, and required an automated cause coding system to which we had no access. We therefore
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expressed Cause of Death as 'cardiovascular' if the International Classification of Disease revision 9 (ICD-9) codes corresponding to cardiovascular codes 390·0 through 429·9 inclusive were recorded in position 1a only. To explore this further, the subgroup of deaths after 1994 where formal Office of National Statistics codes were available for Cause of Death were also examined.
Because of the natural lag time between death and the notification of death processed by the Office of National Statistics, updated death information at the date 31 December 1997 was sought from notifications returned 6 months following the end of the study period. Postmortem data were not used in this study due to the small number of cases with data available.
Statistical analysis
Survival times were calculated by counting the time (in days) from hospital discharge to death or last date known to be alive, with termination of follow-up for all subjects on 31 December 1997. Kaplan-Meier survival curves [13] were constructed for all members of the cohort who had been discharged alive.
A comparison of subsequent survival experience was also made between the study cohort and that expected in the general population. To estimate expected survival, an age-and sex-matched general population cohort was constructed using English Life Tables 1991-3 [14] . A Standardised Mortality Ratio [7] (observed deaths/ expected deaths) was then calculated for each separate year of death. Cox's Proportional Hazards model [15] was also used to compare survival of confirmed and possible myocardial infarction patient survivals, adjusting for age, sex and past history of myocardial infarction. All analysis was carried out using SPSS [16] . Ethical and Local Medical Committee approval were obtained prior to the start of the study.
Results
Patient identification
In 1992, the NHAR recorded 4717 patients admitted with a suspected myocardial infarction, in 960 of whom the diagnosis of myocardial infarction was confirmed (these patients are described in detail elsewhere [2] ). 2363 admissions were considered 'possible myocardial infarction' and these form the basis of this report. The remainder were diagnosed as 'ischaemic heart disease', chest pain of uncertain cause or some other non-cardiac cause.
Of the 2363 'possible myocardial infarction' patients, 647 patients were excluded from further study-125 died in hospital during the index admission; 244 were resident outside the Nottingham Health District; 272 were repeat admissions. Six patients were identifiable on the hospitals' Patient Administration System but no record of them was available on the DHA list of GP-registered patients.
Of the 1716 'possible myocardial infarction' patients remaining in the study, 967 were still registered with local general practitioners, 46 had moved out of the district during the follow-up period and 703 had died by the end of the designated follow up period.
Matching records
The patient list available from the NHAR was checked against the list available from the DHA. For the purposes of the tracing exercise, the DHA list was the reference list. Extensive checks were made to identify, match and locate patients -99·8% of all patients were traced.
Length of follow-up
The study population was followed up on discharge from the index admission until their date of death or the end of the study period on 31 December 1997. The median follow-up period was 5·1 years with a minimum of 0, mean 3·90 and a maximum of 5·99 years (6691 person years of observation). Table 1 shows the baseline characteristics of the cohort. There was a male to female ratio of approximately 1·5:1, with females being on average 5 years older. One third gave a previous history of myocardial infarction. Table 2 shows the patterns of ECG and cardiac enzyme findings. Ten patients lacked ECG data and 11 lacked creatine phosphokinase and lactate dehydrogenase data. Table 3 shows the range of abnormal ECG findings recorded on the study population during their index admission, together with a crude 5-year mortality associated with each of the documented ECG changes. Using the 'initial working diagnosis' recorded by the NHAR, 73% of patients presented with cardiac-sounding chest pain, 13% presented with cardiac failure and 14% presented with other symptoms such as collapse or palpitations of sudden onset. In all patients, however, investigation for a suspected myocardial infarction was the main diagnostic action. Figure 1 shows Kaplan-Meier curves for survival of the whole cohort, the expected survival of an age-and sex-matched general population, and patients with a confirmed myocardial infarction. Five-year survival was strongly related to age, ranging from 93% in those under 45, to 25% in those over 85. Survival in those with no previously documented myocardial infarction (n=1128) was greater than those who gave a history of myocardial infarction (63% vs 50%, P<0·0001).
Clinical data
Survival
Patients with ECG abnormalities in hospital (n=1486) had a worse 5 year survival than those with normal ECGs (n=220) (56% vs 77%, P<0·00001). Patients with cardiac enzyme abnormalities (n=915) were no more likely to die during follow-up than those with normal cardiac enzymes (57% vs 60%, P=0·39.
The survival expected for a normal population of similar age and sex to the study population and annual Standardized Mortality Ratio (SMR) values for each completed year are shown in Table 4 . The 5-year survival of an age-and sex-matched population is also shown in Fig. 1 and was calculated as 76% after 5 years of follow-up. A similar comparison was carried out with patients admitted in the same calendar year with confirmed myocardial infarction [2] . Mortality in the study group was more than three times higher than expected over the first year following discharge and remained significantly higher for a further 3 years. There were proportionately more deaths following discharge in the confirmed myocardial infarction group than the possible 
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myocardial infarction group over the first year, but this pattern was reversed for the remainder of the follow-up period.
The characteristics of patients with confirmed myocardial infarction, assembled in an identical manner from Nottingham hospitals during the same year (1992), have been reported [2] . As expected, age-and sexmatched in-hospital mortality was substantially higher in patients with a confirmed than a possible myocardial infarction (22% vs 7%), but as Fig. 1 shows, survival following discharge was significantly worse in the possible than confirmed myocardial infarction group (63% vs 69% respectively after 4 complete years of follow-up; Log Rank P=0·0016). This finding remained following adjustment for age, sex and past history of myocardial infarction.
Angina was not a primary diagnostic code in the Register, although patients with 'unstable' angina' would be included in the possible myocardial infarction group. Patients who received intravenous nitrates for acute chest pain during admission (n=109) had a 5 year survival following discharge of 72% compared with 57% in those not given such treatment (this finding remained following adjustment for age, sex and past history of myocardial infarction). There were 283 patients who had a single cardiac enzyme rise above twice normal (Table  2) , whose 5 year survival (60%) was similar to patients with lesser or no enzyme rises (58%), a finding that remained following adjustment.
Cause of death
Overall, 53% of deaths during follow-up were attributable to a cardiovascular cause (Table 5 ). There were Expected deaths based on age/sex matched population of n=1716 for possible myocardial infarction patients and 575 confirmed myocardial infarction patients. Standardized mortality ratio (SMR) of 100 would indicate normal population survival experience for the age and sex of each cohort. Survival reported for first 5 years in the possible myocardial infarction cohort and the first 4 years in the confirmed myocardial cohort. small non-significant differences in the proportion of patients assigned to a 'cardiovascular' Cause of Death, depending on the presence or absence of ECG changes at the time of the index admission (55% vs 47% respectively: difference 8·5%, 95% CI 6 to 23%). Data from the subgroup (dying during 1994 or subsequently) with full cause available (n=222) showed that a designated Cause of Death of 'cardiovascular' in this subgroup was 53%, compared with 43·0% for Cause of Death designated as 'cardiovascular' based on 1a alone.
Discussion
Admission to hospital with chest pain is common and is responsible for a considerable and increasing proportion of acute medical admissions [1, 2] . Unlike myocardial infarction, where the natural history after discharge from hospital has been well-described, the outcome of patients in whom an acute infarction is 'excluded' is less clear. A diagnosis of 'possible myocardial infarction' can be compatible with a wide range of subsequent mortality, reflecting the heterogeneous nature of the group. Such wide variation in outcome presumable reflects the likelihood of significant coronary heart disease-some patients probably have no significant coronary heart disease at all, so their likelihood of dying in the 5 years after admission is better than the general population, while others will have significant coronary disease compatible with a reasonable lifespan. Still others will have critical coronary stenoses such that the risk of premature death exceeds even those who have survived a confirmed myocardial infarction.
There are few studies that report survival characteristics on patient groups comparable with that from Nottingham. Reports on a broadly similar (though slightly younger) population suggest that age-and sexstandardized mortality is lower in Denmark than in our patients with a recorded 3 year survival of 81% [7] , compared with 69% in this study. However, different case definitions make direct comparisons difficult.
We cannot be certain what proportion of incident cases are represented in this study. While almost all patients with an acute myocardial infarction will be admitted to hospital [6] , some patients, especially the elderly, may have stayed at home. Patients who presented at hospital (via Accident and Emergency departments or ambulance) may also have been a selected sample of the whole group of incident cases from the community. In addition, patients with suspected infarction may die prior to admission; in the mid 1980s in Nottingham, 22% of patients with a suspected myocardial infarction who had been 'phoned in' died en route to hospital [6] . Interpretation of Cause of Death data is not straightforward [17] , and recent (1993) changes in the coding of death notification require a complex computerized system that is not readily available [12] . For this reason, the designated Cause of Death is an approximation for the overall cohort, but sub-group analysis using office of National Statistics designated Cause of Death data allowed an estimate of potential inaccuracy to be made. This suggests that the 1a estimate of Cause of Death is a minimum, and the allocated cause may be greater than this. For most cases, we did not have post-mortem data to confirm or refute death certificate data.
Differing case definitions can contribute to apparent differences in outcome [3] . Patients in the 'possible myocardial infarction' group may, in other centres applying different case definitions, be diagnosed as acute myocardial infarction, non-Q wave myocardial infarction or unstable angina. Even so, the survival of patients with a single cardiac enzyme rise to above twice the upper limit of normal (n=283), and survival in patients with likely unstable angina (n=109), was actually better than the cohort as a whole (even after adjustment), and did not support such an explanation for the observed mortality. 
Figure 1
The expected survival based on a 'general population' is calculated from the age/sex distribution of the study cohort.
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What might represent optimal management for this group of patients is unclear. Some of the patients in this study died soon after the index event from a variety of causes and the index admission may have represented increasing general morbidity prior to terminal illness -it is unlikely that intervention here may have prevented death. Whilst it is not known to what extent this situation applied to patients in the study, over half of the study group died of coronary heart disease related causes. It has been suggested that the majority of patients admitted with suspected but unconfirmed myocardial infarction have coronary heart disease [7] . Our excess mortality after discharge from hospital is worrying -many patients whose test results show only a modest change may have symptoms which settle quickly and may not be offered a clinic appointment. We have not yet established what proportion of patients have reversible risk factors. Being able to distinguish those patients at high and low risk is important, as it provides opportunities to target clinic follow-up, diagnostic and therapeutic interventions more appropriately and so make better use of finite NHS resources.
Whether identification and treatment of reversible risk factors, or a more intensive programme of symptom control and investigation would have improved survival in this patient group is unclear. However, the mortality of patients admitted with a suspected myocardial infarction in whom the diagnosis is not confirmed is so high that more detailed work is needed to characterise this group and to develop models predictive of those at highest risk.
